LakeShore Biopharma Co., Ltd. (LSBCF) — Total Assets

Annual figures by fiscal year, from SEC filings.

2022: 1.44B CNY2023: 1.72B CNY2024: 1.51B CNY2025: 1.37B CNY1.37B CNY
2022Total Assets (CNY)2025
Fiscal YearTotal AssetsChange YoY
20251.37B CNY-9.6%
20241.51B CNY-12.0%
20231.72B CNY+19.3%
20221.44B CNY